Literature DB >> 16409597

Mammographic appearance of microcalcifications: can they change after neoadjuvant chemotherapy?

Lisa Ellen Esserman, Maria d'Almeida, Darlene Da Costa, Deborah M Gerson, Robert J Poppiti.   

Abstract

Mesh:

Year:  2006        PMID: 16409597     DOI: 10.1111/j.1075-122X.2006.00195.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  5 in total

1.  Microcalcification of Tumor is a Predictor of Response to Neoadjuvant Chemotherapy for Invasive Breast Carcinoma.

Authors:  Aya Murata; Naoko Sannomiya; Naoki Miyamoto; Naoyuki Ueda; Akira Kamida; Yuki Koyanagi; Haruki Nagira; Eriko Matsuda; Yuki Hashimoto; Kengo Sato; Yumi Hirooka; Keiko Hosoya; Yuzo Takagi; Yuko Tanaka; Kunio Araki; Kiyosuke Ishiguro; Yasuaki Hirooka
Journal:  Yonago Acta Med       Date:  2015-08-18       Impact factor: 1.641

2.  Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature.

Authors:  Sommer R Gunia; Mita S Patel; Eleftherios P Mamounas
Journal:  Case Rep Surg       Date:  2012-01-19

3.  Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer.

Authors:  Gi Won Shin; Young Mi Park; Hye Kyoung Yoon; Soo Jin Jung; Tae Hyun Kim; Anbok Lee; Seok Mo Lee
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

4.  The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation.

Authors:  Jun-jie Li; Canming Chen; Yajia Gu; Genhong Di; Jiong Wu; Guangyu Liu; ZhiMin Shao
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

5.  Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.

Authors:  Yeong Yi An; Sung Hun Kim; Bong Joo Kang
Journal:  World J Surg Oncol       Date:  2017-11-06       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.